What is CCNA?
Canadian clinicians and researchers throughout the country came together to form the Canadian Consortium on Neurodegeneration in Aging (CCNA) in 2014 with the goal of accelerating progress in research on age-related neurodegenerative diseases, including Alzheimer’s disease, Vascular dementia, Frontotemporal dementia, and Lewy body dementia.
The Canadian Consortium on Neurodegeneration in Aging (CCNA) entered a Phase III of activities in 2024. Research teams across Canada work in the areas of prevention, treatment, and quality of life. They draw on the data of national platforms, and are supported by the Dementia Research Support Hub.
